Effectiveness and safety of a glutaraldehyde-modified, L-tyrosine-adsorbed and monophosphoryl lipid A-Adjuvanted allergen immunotherapy in patients with allergic asthma sensitized to olive pollen: A retrospective, controlled real-world study.
Allergy to olive pollen is one of the primary causes of allergic asthma in Spain. Even though allergen immunotherapy (AIT) has shown clinical benefits in patients sensitized to different allergens, studies in asthmatic patients sensitized to olive pollen are insufficient. To assess the effectiveness and safety of an ultra-short course of AIT with an L-tyrosine-adsorbed and monophosphoryl lipid A-adjuvanted olive pollen and olive/grass pollen extract (Pollinex Quattro®) in patients with allergic asthma in the real-world setting. Retrospective, controlled study including patients with asthma, wi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | research article |
Erscheinungsdatum: | 2020 |
Schlagwörter: | AAAAI / American Academy of Allergy / Asthma & Immunology / AIT / allergen immunotherapy / ARIA / Allergic Rhinitis and its Impact on Asthma / ARs / adverse reactions / Allergic asthma / Allergic rhinitis / Allergoid / EAACI / European Academy of Allergy and Clinical Immunology / GEMA / “Guía Española para el Manejo del Asma” (Spanish Guidelines for Asthma Management) / GINA / Global Initiative for Asthma / LABAs / long-acting beta-2 agonists / LTRAs / leukotriene receptor antagonists / MCT / microcrystalline tyrosine / MPL / monophosphoryl lipid A / Olive pollen / SABAs / short-acting beta-agonists / SCIT / subcutaneous immunotherapy |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28829324 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/10668/16875 |